iRhythm HoldingsIRTC +1.53%75 3-Year ROIIC % is 21.10 as of Dec. 2025. GuruFocus rates IRTC with a GF Score™ of 75/100 and a GF Value™ of $163.43 (Modestly Undervalued). Among 799 Medical Devices & Instruments companies, iRhythm Holdings ranks better than 70.34% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
iRhythm Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 21.10%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for iRhythm Holdings's 3-Year ROIIC % or its related term are showing as below:
IRTC's 3-Year ROIIC % is ranked better than 70.34% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.67
vs IRTC: 21.10
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
iRhythm Holdings 3-Year ROIIC % Related Terms
iRhythm Holdings 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for iRhythm Holdings's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRTC vs HAE, LIVN, ITGR: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, iRhythm Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Holdings 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where iRhythm Holdings's 3-Year ROIIC % falls into.
iRhythm Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -52.949 (Dec. 2025) - -87.176 (Dec. 2022) )
/
( 338.826 (Dec. 2025) - 176.577 (Dec. 2022) )
=
34.227
/
162.249
=
21.10%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
iRhythm Holdings (IRTC) has a 3-Year ROIIC % of 21.10 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on iRhythm Holdings and its competitors. According to the industry distribution chart, iRhythm Holdings ranks #237 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 29.7%.
Is iRhythm Holdings' 3-Year ROIIC % too high?
iRhythm Holdings' current 3-Year ROIIC % is 21.10. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.67. iRhythm Holdings' value of 21.10 is 1163.5% above this industry median. Based on the distribution chart, iRhythm Holdings ranks #237 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, iRhythm Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' 3-Year ROIIC % compare to HAE and LIVN?
According to the Medical Devices & Instruments industry distribution chart, iRhythm Holdings ranks #237 out of 799 companies for 3-Year ROIIC %. This puts iRhythm Holdings in the upper half of its industry. The industry median 3-Year ROIIC % is 1.67. iRhythm Holdings' value of 21.10 is 1163.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.67, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRhythm Holdings's current 3-Year ROIIC % of 21.10 is 1163.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on iRhythm Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRhythm Holdings's current 3-Year ROIIC % is 21.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Modestly Undervalued. The stock's GF Value™ is $163.43, compared to a current price of $126.48 — trading 22.6% below its estimated fair value. The current 3-Year ROIIC % is 21.10 and 1163.5% above the Medical Devices & Instruments industry median of 1.67. iRhythm Holdings' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current 3-Year ROIIC % is 21.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRhythm Holdings (IRTC) Overvalued in 2026?
Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued.
The current stock price of $126.48 is trading 22.6% below its estimated GF Value™ of $163.43.
GuruFocus considers iRhythm Holdings to be Modestly Undervalued.
Key valuation signals for IRTC:
3-Year ROIIC %: 21.10
GF Value™: $163.43 vs. price of $126.48 (22.6% below fair value)
Industry Position: 1163.5% above the Medical Devices & Instruments median (#237 of 799)
No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
75GF Score
Get the complete analysis for IRTC
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRTC has been successfully added to your 
